scholarly journals Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial

Author(s):  
Rory J. McCrimmon ◽  
Saud Al Sifri ◽  
Rifat Emral ◽  
Viswanathan Mohan ◽  
Leobardo Sauque‐Reyna ◽  
...  
2018 ◽  
Vol 103 (6) ◽  
pp. 2291-2301 ◽  
Author(s):  
Helena W Rodbard ◽  
Ildiko Lingvay ◽  
John Reed ◽  
Raymond de la Rosa ◽  
Ludger Rose ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document